Related Experiment Video
Updated: Mar 15, 2026

10:06
Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence
Published on: February 26, 2018
7.9K
[Mycobacterium lentiflavum lymphadenitis: two case reports]
Ignacio Ruiz Del Olmo Izuzquiza1, María L Monforte Cirac2, Matilde Bustillo Alonso3
1Servicio de Pediatría, Hospital Ernest Lluch Martín, Calatayud, Zaragoza, España. jiruizdelolmo@salud.aragon.es.
Archivos Argentinos De Pediatria
|September 9, 2016
Summary
Nontuberculous mycobacterium (NTM) lymphadenitis is common in children. This report details two cases of Mycobacterium lentiflavum infection, highlighting its emergent nature and varied treatment responses.
Area of Science:
- Pediatric Infectious Diseases
- Microbiology
- Clinical Case Studies
Background:
- Lymphadenitis is the primary manifestation of nontuberculous mycobacterial (NTM) infections in immunocompetent children.
- Mycobacterium lentiflavum is a recently described NTM species with distinct characteristics.
Observation:
- Two pediatric cases of persistent adenopathy were diagnosed with M. lentiflavum lymphadenitis over a decade.
- Diagnostic procedures included routine tests and mycobacterial culture, confirming M. lentiflavum.
- Both patients underwent prolonged oral antibiotic therapy.
Findings:
- One patient required surgical excision after five months of antibiotic treatment.
- The second patient achieved a complete cure with medical therapy alone.
- M. lentiflavum is an emerging NTM pathogen with unique clinical and microbiological profiles.
Implications:
- These cases underscore the need to consider M. lentiflavum in pediatric lymphadenitis evaluations.
- The varied treatment outcomes suggest a need for further research into optimal management strategies for M. lentiflavum infections.
- Increased awareness and reporting of M. lentiflavum cases are crucial due to limited existing literature.
Related Concept Videos
Pulmonary Tuberculosis III
1.3K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.3K
Pulmonary Tuberculosis II
1.9K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.9K
Pulmonary Tuberculosis IV
612
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
612

